Results 191 to 200 of about 182,433 (270)

Efficacy and predictors of pegylated-interferon in hepatitis B surface antigen seroclearance in immune active and inactive chronic hepatitis B patients. [PDF]

J Virus Erad
Han C, Jin L, Zhu M, Qin Q, Li G, Liu Z, Zhang X.   +6 more
europepmc   +1 more source

Impact of Non‐Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha [PDF]

Chujing Li, Lihua Lin, Pei Zhou, Haiyi Cai, Songlian Liu, Xiaoyuan Chen, Aiqi Lu, Bo Li, Yaping Wang, Chuanghua Luo, Jianping Li, Yujuan Guan, Zhiwei Xie   +12 more
openalex   +1 more source

Machine learning model for HBsAg seroclearance after 48-week pegylated interferon therapy in inactive HBsAg carriers: a retrospective study. [PDF]

Virol J
Dong J, Ren S, Zhao J, Wu P, Yu H, Xie Y, Fu J, Mao X, Gao Z, Lin B, Ruan Q, Jiang Y, Xue X, Zhu Y, Zhao H, Cao H, Chen X, Zheng S.   +17 more
europepmc   +1 more source

Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D Infection. [PDF]

J Viral Hepat
Hardtke S, Yurdaydin C, Caruntu FA, Curescu MG, Yalcin K, Akarca US, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Port K, Manns MP, Cornberg M, Kahlhöfer J, Wedemeyer H.   +15 more
europepmc   +1 more source

Single-center real-world data on the efficacy, safety, and current availability of pegylated interferon-α in hematologic neoplasms

Adile Begüm Bahçecioğlu, Yahya Büyükaşık   +1 more
openalex   +2 more sources

Pegylated Interferon-α-Induced Functional Cure for Special Populations with Chronic Hepatitis B Virus Infection: Current Trends, Challenges and Prospection. [PDF]

Drug Des Devel Ther
Zhang Y, Li Y, Lian JQ, Kang W.
europepmc   +1 more source

A machine learning-based predictive model for 48-week hepatitis B surface antigen seroclearance in chronic hepatitis B patients treated with pegylated interferon α-2b: prediction at week 24 [PDF]

Nan Kong, Kaixia Wang, Yiling Wang, Shike Lou, Luocheng Zhou, Tao Wang, Zhili Tan, Lihong Qu   +7 more
openalex   +1 more source

Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia. [PDF]

Front Med (Lausanne)
Wang L, Lu J, Liu D, Ren S, Chen X, Hu Z, Zheng S.   +6 more
europepmc   +1 more source

Organizing pneumonia in a patient following treatment of chronic hepatitis B with pegylated interferon alfa-2b: A case report. [PDF]

IDCases
Tian B, Wang P, Shan C, Gao C, Zhang Q.
europepmc   +1 more source

Pegylated interferon for chronic hepatitis delta: does it still have a role in the bulevirtide era?

Maite González Aldama, Marta Santa Cruz Carrera, Paloma Liendo Arenzana, Sonia Blanco Sampascual, Fernando Menéndez-Blázquez, Paula Rodríguez Gutiérrez, Andrea Pérez Aperribay, Pablo Ruiz-Eguiluz   +7 more
openalex   +1 more source